Clinical Toxicology and Management of Intoxications With Synthetic Cathinones (“Bath Salts”)
Author(s) -
Pedro Mas-Morey,
Mirjam Visser,
L. Winkelmolen,
Daan J. Touw
Publication year - 2012
Publication title -
journal of pharmacy practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.407
H-Index - 28
eISSN - 1531-1937
pISSN - 0897-1900
DOI - 10.1177/0897190012465949
Subject(s) - mephedrone , cathinone , medicine , khat , clinical toxicology , synthetic cannabinoids , stimulant , toxicology , pharmacology , drug , amphetamine , cannabinoid , receptor , dopamine , biology , endocrinology
Synthetic cathinones are synthetic derivatives of the natural cathinone, one of the psychoactive compounds present in Catha edulis (khat). There are at least 12 different types of synthetic cathinones, with mephedrone and 3,4-methylendioxypyrovalerone (MDPV) being the most commonly used by the purchasers. The legal control of these substances is especially difficult because when a specific compound is banned, a new slightly modified chemical variant is introduced into the market. It has been described that patients after taking synthetic cathinones may show signs and symptoms of the sympathicomimetic toxidrome, including agitation, psychosis, tachycardia, hypertension, and seizures. Furthermore, some cases of deaths related to their consumption have also been reported. Nowadays, there is no established treatment protocol for the clinical management of these intoxications. Because of this, we have developed some recommendations that may be useful to determine the treatment of these patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom